Cambridge Investment Research Advisors, Inc.
Position in GERN — Geron Corp
CIK 1419186
FAIRFIELD, IA
Position in GERN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$18,707
-$125,031 QoQ
Shares Held
14,615
-84.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#198
of 258 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $60,632,692 across 72 Biotechnology names. GERN ranks #67 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,946 | $10,901,236 | |
| 2 | EXEL |
Exelixis, Inc.
|
82,212 | $4,473,154 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,186 | $3,922,344 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
35,157 | $3,056,901 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
15,839 | $2,966,327 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,591 | $2,862,672 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
46,210 | $2,520,293 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
30,727 | $2,288,546 |
All Filings in GERN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,707 | 14,615 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $143,738 | 96,469 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $126,376 | 95,740 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $187,724 | 137,025 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $238,325 | 169,025 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $260,744 | 163,990 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $624,774 | 176,490 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $737,477 | 162,440 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $802,314 | 189,225 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $637,477 | 193,175 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $475,537 | 225,373 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $554,369 | 261,495 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $990,654 | 308,615 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $449,439 | 207,115 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $584,384 | 241,481 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $636,107 | 271,841 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $346,953 | 223,841 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $352,023 | 258,841 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $337,685 | 276,791 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $389,725 | 284,471 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $404,135 | 286,621 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $462,341 | 292,621 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $520,416 | 327,306 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $632,159 | 363,310 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $785,349 | 360,252 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $322,837 | 271,292 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||